Yibing Chen

3.3k total citations · 2 hit papers
54 papers, 2.4k citations indexed

About

Yibing Chen is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yibing Chen has authored 54 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 21 papers in Cancer Research and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yibing Chen's work include RNA modifications and cancer (12 papers), Cancer, Hypoxia, and Metabolism (11 papers) and Ferroptosis and cancer prognosis (9 papers). Yibing Chen is often cited by papers focused on RNA modifications and cancer (12 papers), Cancer, Hypoxia, and Metabolism (11 papers) and Ferroptosis and cancer prognosis (9 papers). Yibing Chen collaborates with scholars based in China, United States and Hong Kong. Yibing Chen's co-authors include Zhengzhi Zou, Yucen Song, Wei Du, Longlong Gong, Haocai Chang, Jinliang Xing, Xin Jin, Yanjun Mi, Jianjun Zhu and Haolong Li and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Oncogene.

In The Last Decade

Yibing Chen

52 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tumor-associated macrophages: an accomplice in solid tumor progression

2019 802 citations Yibing Chen, Yucen Song et al. profile →
Dihydroartemisinin-induced unfolded protein response feedback attenuates ferroptosis via PERK/ATF4/HSPA5 pathway in glioma cells

2019 256 citations Yibing Chen, Yanjun Mi et al. Journal of Experimental & Clinical Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yibing Chen China	22	1.4k	815	708	522	494	54	2.4k
Giuseppina Comito Italy	22	1.2k 0.9×	880 1.1×	644 0.9×	350 0.7×	916 1.9×	38	2.4k
Hao Xue China	33	2.0k 1.5×	1.3k 1.6×	677 1.0×	266 0.5×	279 0.6×	86	3.0k
Shu‐Heng Jiang China	26	1.2k 0.9×	792 1.0×	335 0.5×	287 0.5×	439 0.9×	75	2.1k
Lin Cheng China	25	1.9k 1.4×	784 1.0×	465 0.7×	254 0.5×	990 2.0×	75	3.4k
Gianluca Civenni Switzerland	26	1.7k 1.3×	473 0.6×	408 0.6×	281 0.5×	807 1.6×	57	2.7k
Xingjun Jiang China	23	1.1k 0.8×	493 0.6×	298 0.4×	245 0.5×	294 0.6×	106	2.0k
Jason Miska United States	27	1.1k 0.8×	486 0.6×	1.4k 1.9×	270 0.5×	897 1.8×	73	2.8k
Carol A. Sartorius United States	39	1.8k 1.3×	892 1.1×	454 0.6×	338 0.6×	1.5k 3.0×	76	3.7k
Lianfang Zheng China	23	1.1k 0.8×	740 0.9×	309 0.4×	185 0.4×	776 1.6×	44	1.9k
Mingyao Ying United States	22	1.2k 0.8×	493 0.6×	215 0.3×	425 0.8×	359 0.7×	42	2.0k

Countries citing papers authored by Yibing Chen

Since Specialization

Citations

This map shows the geographic impact of Yibing Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yibing Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yibing Chen more than expected).

Fields of papers citing papers by Yibing Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yibing Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yibing Chen. The network helps show where Yibing Chen may publish in the future.

Co-authorship network of co-authors of Yibing Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Yibing Chen. A scholar is included among the top collaborators of Yibing Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yibing Chen. Yibing Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cui, Lei, Yanjun Mi, Qing Tang, et al.. (2025). Ferroptosis in cancer: revealing the multifaceted functions of mitochondria. Cellular and Molecular Life Sciences. 82(1). 277–277. 10 indexed citations

Zhang, Qi, Xiangjie Kong, Sheng Zhang, et al.. (2024). Regulation of α-Ketoglutarate levels by Myc affects metabolism and demethylation in porcine early embryos. Frontiers in Cell and Developmental Biology. 12. 1507102–1507102.

Sun, Junhong, Yuzhen Zhang, Mengru Li, et al.. (2024). An antigen/chemotherapy co-loaded DNA nanocube inserts into tumor cell plasma membrane and enhances chemo- and immunotherapy. International Journal of Pharmaceutics. 669. 125068–125068. 2 indexed citations

Wang, Ning, Mei Chen, Yuan Liao, et al.. (2024). High-adhesion ovarian cancer cell resistance to ferroptosis: The activation of NRF2/FSP1 pathway by junctional adhesion molecule JAM3. Free Radical Biology and Medicine. 228. 1–13. 7 indexed citations

Cheng, Quan, et al.. (2024). The glymphatic system: A new insight into the understanding of neurological diseases. SHILAP Revista de lepidopterología. 2(4). 3 indexed citations

Chen, Yibing, et al.. (2023). Identification of five novel variants of ADAR1 in dyschromatosis symmetrica hereditaria by next-generation sequencing. Frontiers in Pediatrics. 11. 1161502–1161502. 2 indexed citations

Yang, Zhi-hua, Jun Cao, Yucen Song, et al.. (2022). Whole‐exome sequencing identified novel variants in three Chinese Leigh syndrome pedigrees. American Journal of Medical Genetics Part A. 188(4). 1214–1225. 4 indexed citations

Tang, Qing, Xianren Wang, Xin Jin, et al.. (2021). Cisplatin-induced ototoxicity: Updates on molecular mechanisms and otoprotective strategies. European Journal of Pharmaceutics and Biopharmaceutics. 163. 60–71. 94 indexed citations

Qiao, Jianghua, Yibing Chen, Yanjun Mi, et al.. (2020). Macrophages confer resistance to BET inhibition in triple-negative breast cancer by upregulating IKBKE. Biochemical Pharmacology. 180. 114126–114126. 24 indexed citations

10.

Qiao, Jianghua, Yibing Chen, Yanjun Mi, et al.. (2020). NR5A2 synergizes with NCOA3 to induce breast cancer resistance to BET inhibitor by upregulating NRF2 to attenuate ferroptosis. Biochemical and Biophysical Research Communications. 530(2). 402–409. 28 indexed citations

11.

Chen, Yibing, Yucen Song, Yanjun Mi, et al.. (2020). microRNA-499a promotes the progression and chemoresistance of cervical cancer cells by targeting SOX6. APOPTOSIS. 25(3-4). 205–216. 50 indexed citations

12.

Jin, Mingpeng, Jiaojiao Wang, Xiaoying Ji, et al.. (2019). MCUR1 facilitates epithelial-mesenchymal transition and metastasis via the mitochondrial calcium dependent ROS/Nrf2/Notch pathway in hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research. 38(1). 136–136. 129 indexed citations

13.

Sun, Xiacheng, Lei Zhan, Yibing Chen, et al.. (2018). Increased mtDNA copy number promotes cancer progression by enhancing mitochondrial oxidative phosphorylation in microsatellite-stable colorectal cancer. Signal Transduction and Targeted Therapy. 3(1). 8–8. 107 indexed citations

14.

Zhang, Jing, Yibing Chen, Xiaoying Ji, et al.. (2018). Positive feedback loop between mitochondrial fission and Notch signaling promotes survivin-mediated survival of TNBC cells. Cell Death and Disease. 9(11). 1050–1050. 56 indexed citations

15.

Chen, Yibing, Jingjing Zhao, Weiwei Wang, et al.. (2018). SKA1 overexpression is associated with poor prognosis in hepatocellular carcinoma. BMC Cancer. 18(1). 1240–1240. 24 indexed citations

16.

Chen, Yibing, Dujuan Sha, & Jun Zhang. (2017). Treatment of hemorrhagic transformation in patients with ischemic stroke. 25(3). 268–274. 1 indexed citations

17.

Long, Xiaoyu, Xiaoyan Wang, Yibing Chen, et al.. (2017). Polymorphisms in POLG were associated with the prognosis and mtDNA content in hepatocellular carcinoma patients. Bulletin du Cancer. 104(6). 500–507. 4 indexed citations

18.

Wan, Shaogui, Yousheng Wu, Xingchun Zhou, et al.. (2015). Polymorphisms in Genes of Tricarboxylic Acid Cycle Key Enzymes Are Associated with Early Recurrence of Hepatocellular Carcinoma. PLoS ONE. 10(4). e0124471–e0124471. 4 indexed citations

19.

Du, Xiaohong, Shaogui Wan, Yibing Chen, et al.. (2014). Genetic Variants in Genes of Tricarboxylic Acid Cycle Key Enzymes Predict Postsurgical Overall Survival of Patients with Hepatocellular Carcinoma. Annals of Surgical Oncology. 21(13). 4300–4307. 5 indexed citations

20.

Guo, Xu, Deyang Li, Yousheng Wu, et al.. (2014). Genetic variants in genes of tricarboxylic acid cycle key enzymes are associated with prognosis of patients with non-small cell lung cancer. Lung Cancer. 87(2). 162–168. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact